Global Irritable Bowel Syndrome (IBS) Market Research Report 2021

1 Irritable Bowel Syndrome (IBS) Market Overview

1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS)

1.2 Irritable Bowel Syndrome (IBS) Segment by Type

1.2.1 Global Irritable Bowel Syndrome (IBS) Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 IBS-D Drug

1.2.3 IBS-C Drug

1.2.4 Other

1.3 Irritable Bowel Syndrome (IBS) Segment by Application

1.3.1 Irritable Bowel Syndrome (IBS) Sales Comparison by Application: (2021-2027)

1.3.2 Women

1.3.3 Men

1.4 Global Irritable Bowel Syndrome (IBS) Market Size Estimates and Forecasts

1.4.1 Global Irritable Bowel Syndrome (IBS) Revenue 2016-2027

1.4.2 Global Irritable Bowel Syndrome (IBS) Sales 2016-2027

1.4.3 Irritable Bowel Syndrome (IBS) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Irritable Bowel Syndrome (IBS) Market Competition by Manufacturers

2.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturers (2016-2021)

2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Irritable Bowel Syndrome (IBS) Manufacturing Sites, Area Served, Product Type

2.5 Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends

2.5.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue

2.5.3 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Irritable Bowel Syndrome (IBS) Retrospective Market Scenario by Region

3.1 Global Irritable Bowel Syndrome (IBS) Retrospective Market Scenario in Revenue by Region: 2016-2021

3.2 Global Irritable Bowel Syndrome (IBS) Retrospective Market Scenario in Sales by Region: 2016-2021

3.3 North America Irritable Bowel Syndrome (IBS) Market Facts & Figures by Country

3.3.1 North America Irritable Bowel Syndrome (IBS) Sales by Country

3.3.2 North America Irritable Bowel Syndrome (IBS) Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Irritable Bowel Syndrome (IBS) Market Facts & Figures by Country

3.4.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country

3.4.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Irritable Bowel Syndrome (IBS) Market Facts & Figures by Region

3.5.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region

3.5.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Irritable Bowel Syndrome (IBS) Market Facts & Figures by Country

3.6.1 Latin America Irritable Bowel Syndrome (IBS) Sales by Country

3.6.2 Latin America Irritable Bowel Syndrome (IBS) Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Facts & Figures by Country

3.7.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Country

3.7.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4 Global Irritable Bowel Syndrome (IBS) Historic Market Analysis by Type

4.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)

4.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)

4.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2021)

5 Global Irritable Bowel Syndrome (IBS) Historic Market Analysis by Application

5.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)

5.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2021)

5.3 Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2021)

6 Key Companies Profiled

6.1 Bausch Health

6.1.1 Bausch Health Corporation Information

6.1.2 Bausch Health Description and Business Overview

6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.1.4 Bausch Health Product Portfolio

6.1.5 Bausch Health Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Corporation Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.2.4 Allergan Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Corporation Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.3.4 Takeda Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Sucampo Pharmaceuticals (Mallinckrodt)

6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information

6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Description and Business Overview

6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Product Portfolio

6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments/Updates

6.5 Sebela Pharmaceuticals Inc

6.5.1 Sebela Pharmaceuticals Inc Corporation Information

6.5.2 Sebela Pharmaceuticals Inc Description and Business Overview

6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.5.4 Sebela Pharmaceuticals Inc Product Portfolio

6.5.5 Sebela Pharmaceuticals Inc Recent Developments/Updates

6.6 Astellas Pharmaceuticals

6.6.1 Astellas Pharmaceuticals Corporation Information

6.6.2 Astellas Pharmaceuticals Description and Business Overview

6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)

6.6.4 Astellas Pharmaceuticals Product Portfolio

6.6.5 Astellas Pharmaceuticals Recent Developments/Updates

7 Irritable Bowel Syndrome (IBS) Manufacturing Cost Analysis

7.1 Irritable Bowel Syndrome (IBS) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)

7.4 Irritable Bowel Syndrome (IBS) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Irritable Bowel Syndrome (IBS) Distributors List

8.3 Irritable Bowel Syndrome (IBS) Customers

9 Irritable Bowel Syndrome (IBS) Market Dynamics

9.1 Irritable Bowel Syndrome (IBS) Industry Trends

9.2 Irritable Bowel Syndrome (IBS) Growth Drivers

9.3 Irritable Bowel Syndrome (IBS) Market Challenges

9.4 Irritable Bowel Syndrome (IBS) Market Restraints

10 Global Market Forecast

10.1 Irritable Bowel Syndrome (IBS) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Irritable Bowel Syndrome (IBS) by Type (2022-2027)

10.2 Irritable Bowel Syndrome (IBS) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Irritable Bowel Syndrome (IBS) by Application (2022-2027)

10.3 Irritable Bowel Syndrome (IBS) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Irritable Bowel Syndrome (IBS) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer